A new study presented at the American College of Foot and Ankle Surgeons Scientific Conference in Phoenix, AZ, found no significant difference in opioid refills between patients receiving liposomal...
A new study presented at the American College of Foot and Ankle Surgeons Scientific Conference in Phoenix, AZ, found no significant difference in opioid refills between patients receiving liposomal...
A new study presented at the American College of Foot and Ankle Surgeons Scientific Conference in Phoenix, AZ, found no significant difference in opioid refills between patients receiving liposomal...
A new study presented at the American College of Foot and Ankle Surgeons Scientific Conference in Phoenix, AZ, found no significant difference in opioid refills between patients receiving liposomal...
A new study presented at the American College of Foot and Ankle Surgeons Scientific Conference in Phoenix, AZ, found no significant difference in opioid refills between patients receiving liposomal...
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
